Bridging the Gap Between Innovation and Impact: Implementation Science at Birmingham

Originally by: Amy Grove, Professor of Implementation Science, University of Birmingham

Read the original here: https://www.linkedin.com/pulse/from-proof-concept-impact-how-implementation-tc3le/?trackingId=5d7TGbesSN%2BEqMkIJFR7Vg%3D%3D

How do we ensure that innovations developed in health, education or social care make a real difference to the people they are designed to help? This is the central question driving the work of Professor Amy Grove, Professor of Implementation Science at the University of Birmingham, and her team at the Centre for Evidence and Implementation Science. Their research is focused not only on developing knowledge but on ensuring that promising ideas are adopted, embedded and sustained in complex systems.

Implementation science is an emerging discipline with a simple but vital purpose: to improve the uptake, usability and sustainability of research in real-world settings. As Professor Grove explains, some of the best ideas fail not because they are ineffective, but because they are not implemented properly. The consequences of this can be wide-reaching, affecting both the innovators who have invested in development and the people and organisations who might otherwise have benefitted. “Just because something works doesn’t mean it can immediately be adopted. Proving an idea, tool or service can work isn’t always enough to get people to use it. We must understand how it works in the ‘real world’ for the people and organisations who need it most.”

The need for this kind of work is particularly urgent in systems under pressure, such as the NHS or state education. Services are balancing high demand and increasing expectations while struggling with limited resources. In these circumstances, new tools and approaches are welcome, but organisations often lack the time or expertise to stop and examine how best to integrate them. The Centre’s role is to help identify the trade-offs and opportunity costs of adopting innovations, providing clarity on how they can deliver benefits to both organisations and individuals.

In practice, this means working with a range of partners outside higher education, including industry, to answer critical questions about safety, effectiveness, adoption and value for money. The team’s work is rooted in collaboration, ensuring that relevant decision makers are directly engaged in evaluating and refining the pathway from innovation to implementation. A recent example is their partnership with a company that developed a virtual platform for weight management. The platform replicates the support offered via NHS referral routes but provides it at home, potentially easing the burden on overstretched services. However, as Professor Grove notes, “it is complicated to get digital solutions into NHS supply chains and services.” The team is now independently evaluating the platform to assess cost-effectiveness and its viability as an alternative for weight loss programmes. With this evidence, the company is better positioned to consider scaling up its offer.

Opportunities to collaborate with the Centre are open to organisations across a wide spectrum, from health and education to policing and even the cultural sector. Support is available at the stage when a product or service has moved beyond proof of concept and early trials and is ready for more rigorous assessment of its effectiveness and sustainability. The Centre helps partners navigate complex systems, understand barriers to uptake, and build evidence that is fit for purpose. Options for collaboration range from commissioned projects to partnerships on research grants and the hosting of doctoral researchers.

Professor Grove is particularly enthusiastic about two areas shaping the future of the field. The first is the rising profile of implementation science itself. “Increased interest and investment in implementation science from funders is exciting, and we have recently launched the Implementation Science Programme for researchers to help meet the new demand this is generating.” The University of Birmingham is also planning its first Implementation Science Conference in January 2026, a milestone that will highlight the breadth of applications across sectors.

The second is the potential of what she calls “pre-implementation optimisation.” This approach involves future-proofing the design of trials and evaluations by ensuring they are conducted in settings that closely resemble the intended place of use. Factoring in questions of how, where and for whom innovations work at the outset means they can move more quickly from trial to real-world adoption. As Professor Grove explains, “implementation science is all about that and it will be a real game-changer.”

The work of the Centre for Evidence and Implementation Science demonstrates the importance of bridging the gap between innovation and impact. Ideas and technologies alone are not enough; without careful planning, testing and adaptation, they risk falling short of their potential. By focusing on the realities of adoption and sustainability, Professor Grove and her colleagues are ensuring that innovations designed to improve lives can do exactly that.

Author

Leave A Comment

Apply for a complimentary Conference Day VIP Pass

Apply for a complimentary Conference Day VIP Pass

Complimentary Conference Day VIP Passes are reserved for senior leaders and decision-makers with influence over purchasing, commissioning, investment or technology advancements and adoption across UK life sciences.

A Conference Day VIP Pass includes:

  • Complimentary access-all-areas to the Launch Day Conference
  • Access to the dedicated VIP green room alongside Conference speakers
  • Access to all general keynote, panel and programme sessions
  • Curated networking opportunities
  • Opportunities to meet conference speakers and other approved VIP attendees

The VIP Pass applies to the Launch Day Conference only. It does not include admission to the Life Sciences Week Gala Dinner or other separately ticketed events.

Applications are reviewed individually and submitting this form does not guarantee a complimentary pass. To maintain a balanced, high-quality audience, we may limit the number of VIP Passes issued to any one organisation.

    First Name *

    Last Name *

    Work Email Address *

    Telephone Number *

    Job Title *

    Organisation *

    LinkedIn

    Organisation Information

    Which best describes your organisation? *


    If other, please specify

    Which best describes your level of seniority? *

    If other, please specify

    Which areas are you responsible for or directly involved in? *

    If other, please specify

    What best describes your role in purchasing, investment, commissioning or adoption decisions? *

    Attendance Information

    Briefly, what is the number one thing you are hoping to get out of attending Life Sciences Week 2026? *

    Final Confirmation

    Is your role primarily focused on selling products or services, consultancy, account management or business development? *

    Please Confirm *

    I understand that VIP applications are subject to review and approval.
    I understand that the complimentary VIP Pass covers the Life Sciences Week Launch Day Conference only and does not include the Gala Dinner Awards or other separately ticketed events.
    The information supplied in this application is accurate.

    Shabna Raja

    Advisory Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Shabna Raja is a senior leader in enterprise transformation within Life Sciences, with over 20 years’ experience spanning pharma, consumer health and large-scale digital programmes.

    She specialises in bridging strategy and execution – helping organisations translate AI, data and digital innovation into tangible business outcomes. Her work focuses on complex transformation
    initiatives across commercial, data and operating model domains within regulated environments.

    Shabna spent seven years at GSK, where she played a key role in transformation programmes, including as part of the Consumer Health joint venture with Pfizer — one of the most significant integrations in the sector. This experience provided her with deep expertise in  organisational change, integration and operating model evolution at global scale.

    More recently, she has spent over three years working closely with Haleon through a strategic
    services partnership, leading enterprise client engagement and managing a multi-million-pound account while supporting transformation across a newly independent global organisation.

    Her experience spans the end-to-end life sciences value chain, including R&D, commercial, supply chain and patient engagement, giving her a holistic perspective on how technology and transformation can unlock value across the industry.

    Amjad Khan

    Executive Partner,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amjad Khan is a UK-based entrepreneur, AI strategist, and senior technology leader with over 15 years of experience at Pfizer, where he held multiple leadership roles across digital strategy and transformation. As Global Digital Client Partner, he was responsible for digital strategy and execution across Global Business Units covering Vaccines, Hospital, and Medical Affairs. Most notably, he led the commercial launch for the Covid franchise transforming and accelerating the model for how new medicines are brought to market.

    Following his tenure at Pfizer, Amjad channelled his expertise into building at the frontier of AI. His work spans AI leadership, stakeholder engagement, and agile delivery helping organisations adopt and scale emerging  technologies to drive meaningful outcomes.

    Dr. Richard Fallon | Business Consultant | WM Life Sciences

    Dr. Richard Fallon

    Co Founder, Life Sciences Week 
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Dr Richard Fallon is an entrepreneur and ecosystem builder who connects industry leaders, investors and public-sector stakeholders to accelerate collaboration and commercial growth.

    As the Founder of the Technology Supply Chain and co-founder of the Innovation Awards, he has spent more than two decades convening influential networks that help emerging businesses find capital, strategic partners and new routes to market.

    Richard’s work spans leadership and consultancy across major organisations, alongside building membership and partnership platforms that bring universities, industry and investors into the same room – and turn conversations into practical outcomes.

    With his focus on life sciences, Richard supports organisations and people driving breakthroughs in healthcare, biotechnology, medical technology and advanced research. He is passionate about creating the conditions for transformative ideas to move from concept to real-world impact – by connecting innovators with the funding, expertise and opportunities they need to scale.

    Through Life Sciences Week, Richard is championing the UK’s world-class life sciences community and helping position it at the forefront of innovation, investment and patient outcomes.

    Amy Deakin | Chief of Staff | WM Life Sciences

    Amy Deakin

    Event Managing Director,
    Life Sciences Week
    +44 (0) 121 227 4156
    info@lifesciencesweek.co.uk

    Bio

    Amy Deakin is a Birmingham-based leader specialising in building partnerships and fostering innovation in the life sciences sector. With a degree in Sport and Exercise Science, Amy brings a grounded understanding of human health and performance to her work and a strong interest in the developments shaping healthcare today.

    Amy is Managing Director of Life Sciences Week, part of the One Thousand Trades Group, and also serves as Director of One Thousand Trades Events. In these roles, she convenes researchers, clinicians and industry leaders to strengthen collaboration, unlock new partnerships and help accelerate real-world innovation across the life sciences ecosystem.

    Her career spans both commercial and third-sector environments. She began in automotive design, delivering projects for Volkswagen, McLaren, Bentley and Jaguar Land Rover, before moving into the third sector with Acorns Children’s Hospice. She later joined Western Union, working as a Partnerships Manager for international payments

    An avid netballer, Amy is a committed advocate for health and wellbeing – bringing energy, clarity and connection to everything she builds, and actively involved as a participant in health related research studies.

      Award Category Voting

      Here's a list of all categories you can vote for. Simply click each category to cast your vote. Voting in each category is not mandatory, so please feel free to click just the category that interests you.

      Day you've not voted in, will be denoted with an ❌

      If you're having issues submitting the form, please ensure all the category boxes are closed and try again.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteProf. Alex RichterBlack Space TechnologyAston Vision Sciences

      Celebrating an emerging leader making significant contributions to the field through research, innovation, or leadership.

      Recognising pioneering research, technology, or therapies that are transforming healthcare and biotechnology.

      No VoteShashank Chaganty – VichagLeah Vanono - PBS InnovationsKloe Avon- KZ Organics

      Honouring successful cross-sector partnerships driving advancements in life sciences, from academia to industry.

      No VoteProf Liam Grover- WMHTIAJudith Stewart- Health Innovation West MidlandsAdam McGuinness - Plug and Play

      Awarding an individual or organisation for exceptional long-term impact on the industry.

      No VoteDavid KidneyMedilink MidlandsUniversity of Birmingham

      Highlighting innovations in treatments, diagnostics, or healthcare delivery that have significantly improved patient outcomes.

      No VoteJean-Louis Duprey - Linear DiagnosticsSian Dunning - MD-TECKarim Vissangy - HoloMedix

      Your Details